Number of women | Number of events | Crude analysis | Adjusted modela | |||
---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |||
Proximal RCA | ||||||
0–4 years | 27 | 7 | 2.31 | (0.98–5.44) | 2.22 | (0.94–5.23) |
4–8 years | 49 | 21 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 106 | 8 | 1.12 | (0.41–3.10) | 1.18 | (0.42–3.29) |
Mid RCA | ||||||
0–4 years | 30 | 25 | 1.89 | (0.91–3.94) | 1.74 | (0.83–3.64) |
4–8 years | 50 | 10 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 102 | 9 | 0.91 | (0.37–2.23) | 1.00 | (0.4–2.48) |
Distal RCA | ||||||
0–4 years | 15 | 9 | 2.42 | (0.66–8.95) | 2.03 | (0.54–7.59) |
4–8 years | 50 | 3 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 117 | 4 | 1.31 | (0.29–5.84) | 1.71 | (0.38–7.82) |
LMCA | ||||||
0–4 years | 8 | 1 | 0.82 | (0.05–13.1) | NA | |
4–8 years | 54 | 1 | 1.00 | Ref. | ||
8+ years | 120 | 3 | 2.94 | (0.31–28.3) | ||
Proximal LAD | ||||||
0–4 years | 24 | 20 | 1.20 | (0.60–2.42) | 1.18 | (0.58–2.38) |
4–8 years | 55 | 13 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 103 | 11 | 0.89 | (0.40–1.98) | 0.93 | (0.41–2.10) |
Mid LAD | ||||||
0–4 years | 30 | 24 | 1.30 | (0.67–2.51) | 1.23 | (0.63–2.38) |
4–8 years | 54 | 14 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 98 | 14 | 1.07 | (0.51–2.25) | 1.16 | (0.55–2.46) |
Distal LAD | ||||||
0–4 years | 9 | 2 | 1.65 | (0.15–18.2) | NA | |
4–8 years | 52 | 1 | 1.00 | Ref. | ||
8+ years | 121 | 4 | 3.93 | (0.44–35.2) | ||
Proximal LCX | ||||||
0–4 years | 18 | 12 | 2.40 | (0.77–7.45) | 2.18 | (0.70–6.78) |
4–8 years | 49 | 4 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 115 | 12 | 3.08 | (0.99–9.54) | 4.12 | (1.31–13.0) |
Any segment | ||||||
0–4 years | 79 | 78 | 1.21 | (0.82–1.79) | 1.10 | (0.74–1.63) |
4–8 years | 45 | 38 | 1.00 | Ref. | 1.00 | Ref. |
8+ years | 58 | 45 | 2.22 | (1.44–3.43) | 2.58 | (1.65–4.01) |